Yang Rui continued to work hard in the laboratory, as if he wanted to make up for all the time he had wasted recently. Watermark Ad Test Watermark Ad Test

In fact, it was Yang Rui who didn't dare to show his head easily.

As long as he walks out now, he will immediately have long guns and short cannons waiting for him, don't speak, if you want to be told to play a big name, if you speak, it is easy to say the wrong thing.

As for Lu Boding, the facts are there, and there is no need for him to say anything more.

After all, there is no sales in China, and what will be dealt with in the end is the Jingxi Pharmaceutical General Factory, and there are a few unlucky flag-waving goods, and the rest of the time is mainly to watch the fire from the other side.

Look at the fire in the United States that is burning more and more fiercely, and it is burning more and more.

The more intense the fire in the United States burns, the more happiness it leaves for the Chinese people.

On August 26, the U.S. reported death toll officially exceeded the 5,000 mark.

On August 27, that number exceeded a staggering 6,000.

On August 28, the number of people in the United States was more than 8,000 in the United States......

By September 1, 10,000 people had died in the United States as a result of Legal.

At the same time, more than 2,000 people died in Germany, the first country in Europe to pass the law. Europe-wide statistics are not yet known.

Even the Chinese media have been refreshed again and again by these figures.

In modern society, except for local wars, there are few thousands of deaths, in fact, even in wars, it is difficult to say how many people died, and it is very difficult to photograph the remains of the dead or the bodies of refugees.

However, the incident of medical death is different, behind each deceased, there is a living family, and there is a body covered with a white cloth.

The news circles all over the world were swept up by Lu Boding for a while.

At the same time, reports about Yang Rui gradually spread.

Miki is a giant company, and Lybordin, as a blockbuster of the new generation, has the full support of Miki - if it weren't for the fatality problem, the anti-heart rhythm drugs like Lyber could bring in $100 billion in revenue over the next decade.

100 billion US dollars, equivalent to China's foreign exchange reserves for ten years, so in order to earn this money, Miki Company has carried out a huge publicity and marketing throughout the United States.

They have hundreds of medical representatives who are used to market to 10,000 cardiologists, and they have the killer measure of using free trials to PR doctors and patients.

In the '80s, before the law required doctors to sign trial drugs, the 18 largest pharmaceutical companies in the United States distributed 2.4 billion free trial drugs, an average of 10 for each American.

In addition, the giving of souvenirs and gifts also guarantees the marketing of medical representatives to doctors. Doctors get everything from beach bags, coffee cups, stethoscopes, notepads to tickets to receptions with cheerleaders, tennis practice tickets, gourmet meals, cruises, free airfares......

For high-end doctors and academics, pharmaceutical companies may even give away tens of thousands of dollars worth of medical systems or retraining programs. Doctors who are qualified to attend seminars often have the opportunity to ski and play golf in between seminars, as pharmaceutical companies always like to hold such seminars in scenic spots.

As for the more advanced academics, such as those employed by the National Institutes of Health or the FDA, they can even receive a reasonable and legal salary from pharmaceutical companies, attend conferences or write articles, and they can also get a lot of money. Most of the top medical researchers in the United States can earn more than their positions as a result.

Such a reality has brought the American medical community into a mysterious state.

No one points out the problem of the lawyer, or even if anyone points out the problem of the lawyer, these people are inconsequential figures.

The bigwigs, the bigwigs in the pharmaceutical industry, whether they are paid or not, have a deep belief in Lybodin.

The side effects of Libodine are indeed hidden, but the inaction of scholars in the medical field is also one of the reasons.

In the end, it was a scholar from China who lifted the lid.

Yang Rui has not received benefits from Miki's company, nor has he participated in seminars held or jointly organized by Miki, let alone received a salary from Miki, so there will be no Miki

It's a bit embarrassing.

However, Americans also have a way to deal with this kind of thing, just like every time the Ebola virus breaks out, there will be brave and fearless African doctors who will be alive and well.

Yang Rui soon received the treatment of an African doctor as well.

The Washington Post was the first to open up, praising Yang Rui as "not only an outstanding scholar, but also a moral role model for young people." He withstood the pressure and protected tens of thousands of Chinese under extremely harsh conditions. ”

Not to be outdone, the Los Angeles Times followed suit with an article saying that "Yang Rui's performance proves not only his ability, but also the conscience of scholars, and the FDA should learn from the Chinese." ”

More direct praise came from the academic community, and the news that the New England Journal of Medicine had asked Yang Rui to write about the issue of legal advice quickly spread throughout the academic community.

Manuscript requests for academic journals are actually a common thing, especially in the era when a few people hold the truth, and top journals will publish special manuscripts in each issue.

For example, when Apollo flies into the sky, the human genome project is made, or in smaller events, such as the sudden appearance of a genetically modified seed, and so on, journals will ask for manuscripts from scholars in the field when they can't wait for the articles that will automatically come to their doors.

Of course, journals of different grades should choose scholars of different grades, otherwise it is common for manuscripts to be rejected without replying.

However, the New England Journal of Medicine is a top journal in the medical field, and his invitation letter will basically not be rejected.

Yang Rui naturally would not refuse.

To put it mildly, to be able to publish an article in the "New England Journal of Medicine" is no weaker than "LL", and in 85 years in China, this is a proper academician-level achievement.

As for the manuscript, it can be regarded as a capital to show off, and any academician who has a manuscript from the New England Journal of Medicine can blow it for almost a lifetime.

However, in today's situation, neither the researchers at the Ion Channel Lab nor the researchers at Sinovel Labs expressed surprise, as if they should have been.

Yang Rui simply nested in the laboratory to write articles for the New England Journal of Medicine, and the other party asked for a short article, with a total length of less than 2,000 words, preferably 1,200 words, exactly three pages or four pages with pictures.

Yang Rui didn't want to write too long, and only regarded it as an achievement.

And the turmoil outside the laboratory was temporarily left behind by Yang Rui.

m.MM provides reborn god-level scholars without pop-ups to read high-quality full-text chapters online,High-speed first release of the latest chapters,Higher text quality,If you think MM is good, please help us promote and recommend this site,Thank you for your support!Your every sharing and publicity is the driving force for our high-speed debut!